Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Norman

Showing results (1-10 of 327) with videos related to

Pageof 33
Sort By:
Health Estate|July 6, 2010
Dirty ducting poses significant risksRichard Norman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 30, 2011
100 years. Looking back. Skill, drive and luck: the discovery and development of heparinRichard Norman
Health Estate|October 7, 2014
TR/19 update--key concerns addressedRichard Norman
Journal of Health Organization and Management|November 12, 2015
Lessons from Albion: Can Australia learn from England's approach to primary healthcare funding?Richard Norman, Suzanne Robinson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Competing Views on the English EQ-5D-5L Valuation SetRichard Norman, Jan Abel Olsen
International Journal of Cardiology|June 12, 2018
Squaring up the health economics of PCSK9 monoclonal antibodies 'down under'Gerald F Watts, Richard Norman
Journal of Cataract and Refractive Surgery|July 30, 2013
Tri-soft shell techniqueSteve A Arshinoff, Richard Norman
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 8, 2022
Expanding the Scope of Value for Economic Evaluation: The EQ-HWBRichard Norman, Jan Abel Olsen
The Medical Journal of Australia|May 6, 2014
The desire and capability of Australian general practitioners to change their working hoursRichard Norman, Jane P Hall
Health Economics|November 29, 2021
Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis)Marcel F Jonker, Richard Norman
Pageof 33

Showing results (1-10 of 327) with videos related to

Sort By:
Pageof 33
Health Estate|July 6, 2010
Dirty ducting poses significant risksRichard Norman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 30, 2011
100 years. Looking back. Skill, drive and luck: the discovery and development of heparinRichard Norman
Health Estate|October 7, 2014
TR/19 update--key concerns addressedRichard Norman
Journal of Health Organization and Management|November 12, 2015
Lessons from Albion: Can Australia learn from England's approach to primary healthcare funding?Richard Norman, Suzanne Robinson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Competing Views on the English EQ-5D-5L Valuation SetRichard Norman, Jan Abel Olsen
International Journal of Cardiology|June 12, 2018
Squaring up the health economics of PCSK9 monoclonal antibodies 'down under'Gerald F Watts, Richard Norman
Journal of Cataract and Refractive Surgery|July 30, 2013
Tri-soft shell techniqueSteve A Arshinoff, Richard Norman
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 8, 2022
Expanding the Scope of Value for Economic Evaluation: The EQ-HWBRichard Norman, Jan Abel Olsen
The Medical Journal of Australia|May 6, 2014
The desire and capability of Australian general practitioners to change their working hoursRichard Norman, Jane P Hall
Health Economics|November 29, 2021
Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis)Marcel F Jonker, Richard Norman
Pageof 33